Harvest Fund Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Sell |
28,427
-693
| -2% | -$48.3K | 0.08% | 140 |
|
|
2025
Q4 | $1.93M | Buy |
29,120
+5,052
| +21% | +$327K | 0.07% | 154 |
|
|
2025
Q3 | $1.62M | Sell |
24,068
-11,389
| -32% | -$901K | 0.07% | 159 |
|
|
2025
Q2 | $3.09M | Buy |
35,457
+4,750
| +15% | +$372K | 0.15% | 112 |
|
|
2025
Q1 | $2.1M | Buy |
30,707
+4,400
| +17% | +$359K | 0.1% | 137 |
|
|
2024
Q4 | $2.01M | Buy |
26,307
+7,848
| +43% | +$581K | 0.09% | 143 |
|
|
2024
Q3 | $1.24M | Buy |
18,459
+6,425
| +53% | +$528K | 0.07% | 168 |
|
|
2024
Q2 | $1.36M | Sell |
12,034
-3,128
| -21% | -$395K | 0.1% | 127 |
|
|
2024
Q1 | $2.1M | Buy |
15,162
+11,767
| +347% | +$1.48M | 0.19% | 92 |
|
|
2023
Q4 | $415K | Buy |
3,395
+343
| +11% | +$35K | 0.06% | 128 |
|
|
2023
Q3 | $285K | Sell |
3,052
-3,042
| -50% | -$343K | 0.05% | 171 |
|
|
2023
Q2 | $783K | Buy |
6,094
+793
| +15% | +$95.9K | 0.16% | 76 |
|
|
2023
Q1 | $616K | Buy |
5,301
+2,146
| +68% | +$240K | 0.14% | 81 |
|
|
2022
Q4 | $333K | Buy |
3,155
+2,970
| +1,605% | +$326K | 0.09% | 143 |
|
|
2022
Q3 | $15K | Buy |
185
+77
| +71% | +$6.52K | ﹤0.01% | 589 |
|
|
2022
Q2 | $8K | Hold |
108
| – | – | ﹤0.01% | 637 |
|
|
2022
Q1 | $13K | Sell |
108
-4,996
| -98% | -$546K | ﹤0.01% | 627 |
|
|
2021
Q4 | $690K | Buy |
5,104
+2,884
| +130% | +$414K | 0.12% | 73 |
|
|
2021
Q3 | $303K | Buy |
+2,220
| New | +$280K | 0.07% | 95 |
|
|
2021
Q1 | – | Sell |
-796
| Closed | -$73K | – | 826 |
|
|
2020
Q4 | $73K | Sell |
796
-3,284
| -80% | -$293K | 0.01% | 307 |
|
|
2020
Q3 | $390K | Buy |
4,080
+932
| +30% | +$97.4K | 0.03% | 100 |
|
|
2020
Q2 | $314K | Buy |
3,148
+208
| +7% | +$18.6K | 0.03% | 99 |
|
|
2020
Q1 | $197K | Buy |
2,940
+1,196
| +69% | +$74.4K | 0.02% | 126 |
|
|
2019
Q4 | $146K | Buy |
1,744
+888
| +104% | +$42.1K | 0.02% | 146 |
|
|
2019
Q3 | $32K | Buy |
+856
| New | +$33.3K | ﹤0.01% | 336 |
|
|
2019
Q2 | – | Sell |
-1,168
| Closed | -$35K | – | 390 |
|
|
2019
Q1 | $35K | Sell |
1,168
-8,792
| -88% | -$309K | 0.01% | 317 |
|
|
2018
Q4 | $298K | Sell |
9,960
-580
| -6% | -$18.4K | 0.06% | 77 |
|
|
2018
Q3 | $377K | Buy |
10,540
+9,308
| +756% | +$289K | 0.06% | 77 |
|
|
2018
Q2 | $29K | Buy |
+1,232
| New | +$26.1K | ﹤0.01% | 259 |
|
Other funds holding DXCM
VCM
VPM
Harvest Fund Management's DXCM Position: Q1 2026 in Review
Harvest Fund Management reduced its DexCom (DXCM) stake by 2.4% in Q1 2026, selling an estimated $48.3K and leaving 28,427 shares worth $1.78M. The position accounts for 0.08% of the portfolio, ranked #140.
Harvest Fund Management first reported a position in DXCM in Q2 2018 and has held it in 29 quarters since. The position peaked at $3.09M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Harvest Fund Management held 28,427 shares of DexCom worth $1.78M as of Q1 2026.
- Harvest Fund Management sold 693 DexCom shares in Q1 2026, an estimated $48.3K.
- DexCom made up 0.08% of Harvest Fund Management's portfolio in Q1 2026, its #140 holding.
- Harvest Fund Management first reported a position in DexCom in Q2 2018 and has held it in 29 quarters since.
- Harvest Fund Management's DexCom position peaked at $3.09M in Q2 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.